Elevated serum CA72-4 levels predict poor prognosis in pancreatic adenocarcinoma after intensity-modulated radiation therapy

Carbohydrate antigen 72-4 (CA72-4) is a human tumor-associated glycoprotein, commonly used as a tumor marker for diagnosing and predicting outcome in gastric and ovarian cancers. However, the relationship between serum CA72-4 levels and prognosis of pancreatic adenocarcinoma has not been fully eluci...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Peng, Zhu, Yuan, Liu, Luying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496241/
https://www.ncbi.nlm.nih.gov/pubmed/25860937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496241/
https://www.ncbi.nlm.nih.gov/pubmed/25860937

Ejemplares similares